Skip to Content

AmericaFirst Monthly Risk-On Risk-Off A ABRFX

Medalist Rating as of | See America First Investment Hub
  • NAV / 1-Day Return 14.38  /  +1.13 %
  • Total Assets 5.0 Mil
  • Adj. Expense Ratio
    2.870%
  • Expense Ratio 2.870%
  • Distribution Fee Level High
  • Share Class Type Front Load
  • Category Tactical Allocation
  • Investment Style Mid Growth
  • Credit Quality / Interest Rate Sensitivity
  • Status Open
  • TTM Yield
  • Turnover 326%

USD | NAV as of Mar 18, 2024 | 1-Day Return as of Mar 18, 2024, 10:14 PM GMT+0

Morningstar’s Analysis ABRFX

Will ABRFX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in AmericaFirst Monthly Risk-On Risk-Off A's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ABRFX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 51.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cash & Cash Equivalents

13.22 676,889
Cash and Equivalents

Nu Holdings Ltd Ordinary Shares Class A

8.05 411,866
Financial Services

TG Therapeutics Inc

7.01 358,951
Healthcare

Gritstone Bio Inc

6.00 307,000
Healthcare

Monte Rosa Therapeutics Inc

5.41 276,716
Healthcare

Eli Lilly and Co

5.12 262,281
Healthcare

Novo Nordisk A/S ADR

4.68 239,540
Healthcare

Meta Platforms Inc Class A

4.08 208,795
Communication Services

NVIDIA Corp

3.86 197,780
Technology

DraftKings Inc Ordinary Shares - Class A

3.85 196,889
Consumer Cyclical